Mazor Robotics Ltd. (NASDAQ:MZOR) had its price objective upped by Barclays PLC from $24.00 to $28.00 in a research report released on Tuesday. Barclays PLC currently has an overweight rating on the stock.
Other research analysts also recently issued research reports about the company. Zacks Investment Research downgraded Mazor Robotics from a buy rating to a hold rating in a research note on Wednesday, September 14th. Needham & Company LLC reaffirmed a hold rating on shares of Mazor Robotics in a research note on Tuesday, August 2nd. Standpoint Research began coverage on Mazor Robotics in a research note on Friday, July 8th. They issued a buy rating and a $30.00 price objective for the company. Finally, B. Riley initiated coverage on Mazor Robotics in a research note on Thursday, October 6th. They issued a neutral rating and a $25.00 price objective for the company. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of Hold and a consensus price target of $26.25.
Mazor Robotics (NASDAQ:MZOR) traded down 0.189% on Tuesday, reaching $23.705. 23,172 shares of the company traded hands. The stock’s market capitalization is $513.76 million. Mazor Robotics has a one year low of $8.31 and a one year high of $26.55. The firm has a 50 day moving average of $23.40 and a 200-day moving average of $18.37.
Mazor Robotics (NASDAQ:MZOR) last issued its earnings results on Tuesday, August 2nd. The company reported ($0.09) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.11) by $0.02. The firm earned $8.30 million during the quarter, compared to the consensus estimate of $8.51 million. Mazor Robotics had a negative return on equity of 42.30% and a negative net margin of 60.75%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.05) earnings per share. On average, analysts anticipate that Mazor Robotics will post ($0.71) EPS for the current year.
Several hedge funds have recently modified their holdings of MZOR. Cookson Peirce & Co. Inc. acquired a new stake in shares of Mazor Robotics during the second quarter worth about $192,000. Trellus Management Company LLC increased its stake in shares of Mazor Robotics by 11.6% in the second quarter. Trellus Management Company LLC now owns 23,982 shares of the company’s stock worth $431,000 after buying an additional 2,500 shares during the period. Menta Capital LLC increased its stake in shares of Mazor Robotics by 81.9% in the first quarter. Menta Capital LLC now owns 37,482 shares of the company’s stock worth $466,000 after buying an additional 16,879 shares during the period. Candriam Luxembourg S.C.A. acquired a new stake in shares of Mazor Robotics during the second quarter worth about $1,079,000. Finally, Iguana Healthcare Management LLC increased its stake in shares of Mazor Robotics by 384.6% in the first quarter. Iguana Healthcare Management LLC now owns 121,151 shares of the company’s stock worth $1,507,000 after buying an additional 96,151 shares during the period. Hedge funds and other institutional investors own 18.72% of the company’s stock.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.